• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Secukinumab decreased circulating anti-BP180-NC16a autoantibodies in a patient with coexisting psoriasis vulgaris and bullous pemphigoid.

作者信息

Kamata Masahiro, Asano Yoshihide, Shida Rino, Maeda Narumi, Yoshizaki Ayumi, Miyagaki Tomomitsu, Kawashima Tomohiko, Tada Yayoi, Sato Shinichi

机构信息

Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan.

Department of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.

出版信息

J Dermatol. 2019 Jun;46(6):e216-e217. doi: 10.1111/1346-8138.14760. Epub 2019 Jan 10.

DOI:10.1111/1346-8138.14760
PMID:30628103
Abstract
摘要

相似文献

1
Secukinumab decreased circulating anti-BP180-NC16a autoantibodies in a patient with coexisting psoriasis vulgaris and bullous pemphigoid.司库奇尤单抗降低了一名同时患有寻常型银屑病和大疱性类天疱疮患者循环中的抗BP180-NC16a自身抗体水平。
J Dermatol. 2019 Jun;46(6):e216-e217. doi: 10.1111/1346-8138.14760. Epub 2019 Jan 10.
2
Pustular psoriasis associated with bullous pemphigoid with fluctuating anti-BP180 antibody titre according to the condition of pustular lesions.
Eur J Dermatol. 2021 Feb 1;31(1):107-109. doi: 10.1684/ejd.2021.3974.
3
Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity.IgE 自身抗体对 BP180 的血清水平与大疱性类天疱疮疾病活动的相关性。
JAMA Dermatol. 2017 Jan 1;153(1):30-38. doi: 10.1001/jamadermatol.2016.3357.
4
BPDAI and ABSIS correlate with serum anti-BP180 NC16A IgG but not with anti-BP230 IgG in patients with bullous pemphigoid.BPDAI 和 ABSIS 与大疱性类天疱疮患者血清抗 BP180 NC16A IgG 相关，但与抗 BP230 IgG 不相关。
Arch Dermatol Res. 2018 Apr;310(3):255-259. doi: 10.1007/s00403-018-1817-9. Epub 2018 Feb 8.
5
Possible paraneoplastic syndrome case of bullous pemphigoid with immunoglobulin G anti-BP180 C-terminal domain antibodies associated with psoriasis and primary macroglobulinemia.大疱性类天疱疮伴免疫球蛋白G抗BP180 C末端结构域抗体，与银屑病和原发性巨球蛋白血症相关的可能副肿瘤综合征病例。
J Dermatol. 2016 May;43(5):571-4. doi: 10.1111/1346-8138.13170. Epub 2015 Oct 28.
6
Possible correlation of IgE autoantibody to BP180 with disease activity in bullous pemphigoid.大疱性类天疱疮中IgE抗BP180自身抗体与疾病活动度的可能相关性。
J Dermatol Sci. 2015 Apr;78(1):77-9. doi: 10.1016/j.jdermsci.2015.02.009. Epub 2015 Feb 24.
7
Erythema With Nonscarring, Tense Blister Formation Without Circulating Anti-BP180 Antibodies.
JAMA Dermatol. 2017 Nov 1;153(11):1185-1186. doi: 10.1001/jamadermatol.2017.2058.
8
Detection of anti-BP180 NC16A autoantibodies after the onset of dipeptidyl peptidase-IV inhibitor-associated bullous pemphigoid: a report of three patients.二肽基肽酶-IV抑制剂相关大疱性类天疱疮发病后抗BP180 NC16A自身抗体的检测：三例报告
Br J Dermatol. 2018 Sep;179(3):790-791. doi: 10.1111/bjd.16656. Epub 2018 Jun 25.
9
Pemphigoid with antibodies to laminin γ1, BP180 and BP230, associated with psoriasis vulgaris: successful disease control with cyclosporin.伴有抗层粘连蛋白γ1、BP180和BP230抗体的类天疱疮，与寻常型银屑病相关：环孢素成功控制病情。
J Dermatol. 2015 Apr;42(4):394-7. doi: 10.1111/1346-8138.12798. Epub 2015 Feb 24.
10
The Anti-C1s Antibody TNT003 Prevents Complement Activation in the Skin Induced by Bullous Pemphigoid Autoantibodies.抗C1s抗体TNT003可预防大疱性类天疱疮自身抗体诱导的皮肤补体激活。
J Invest Dermatol. 2018 Feb;138(2):458-461. doi: 10.1016/j.jid.2017.08.030. Epub 2017 Sep 9.

引用本文的文献

1
Recent advances in the genetics and innate immune cells of bullous pemphigoid.大疱性类天疱疮的遗传学和固有免疫细胞的最新进展。
Front Immunol. 2025 Jun 18;16:1530407. doi: 10.3389/fimmu.2025.1530407. eCollection 2025.
2
Bullous Pemphigoid Overlapping Psoriasis Vulgaris: A Rare Case Report and Literature Review.大疱性类天疱疮重叠寻常型银屑病：1例罕见病例报告及文献复习
Clin Pract. 2025 May 8;15(5):91. doi: 10.3390/clinpract15050091.
3
A systematic review of the role of interleukin-17 inhibitors in bullous pemphigoid: therapeutic and paradoxical effects.
白细胞介素-17抑制剂在大疱性类天疱疮中的作用的系统评价：治疗作用与矛盾效应
Arch Dermatol Res. 2025 Mar 11;317(1):544. doi: 10.1007/s00403-025-04052-x.
4
Updates on the Management of Autoimmune Bullous Diseases.自身免疫性大疱性疾病的治疗进展
Indian Dermatol Online J. 2024 Aug 30;15(5):758-769. doi: 10.4103/idoj.idoj_740_23. eCollection 2024 Sep-Oct.
5
Bullous pemphigoid burden of disease, management and unmet therapeutic needs.大疱性类天疱疮的疾病负担、管理及未满足的治疗需求。
J Eur Acad Dermatol Venereol. 2025 Feb;39(2):290-300. doi: 10.1111/jdv.20313. Epub 2024 Sep 19.
6
Spesolimab in the Management of Generalized Pustular Psoriasis With Concurrent Bullous Pemphigoid and Psoriasis.司库奇尤单抗用于治疗合并大疱性类天疱疮和银屑病的泛发性脓疱型银屑病
Cureus. 2024 May 15;16(5):e60331. doi: 10.7759/cureus.60331. eCollection 2024 May.
7
Advancements in Bullous Pemphigoid Treatment: A Comprehensive Pipeline Update.大疱性类天疱疮治疗的进展：全面的药物研发管线更新。
Am J Clin Dermatol. 2024 Mar;25(2):195-212. doi: 10.1007/s40257-023-00832-1. Epub 2023 Dec 29.
8
Advancing Treatment in Bullous Pemphigoid: A Comprehensive Review of Novel Therapeutic Targets and Approaches.推进大疱性类天疱疮的治疗：新型治疗靶点和方法的全面综述。
Clin Rev Allergy Immunol. 2023 Dec;65(3):331-353. doi: 10.1007/s12016-023-08973-1. Epub 2023 Oct 28.
9
Targeting type 2 inflammation in bullous pemphigoid: current and emerging therapeutic approaches.靶向大疱性类天疱疮中的2型炎症：当前及新兴治疗方法
Front Med (Lausanne). 2023 Aug 8;10:1196946. doi: 10.3389/fmed.2023.1196946. eCollection 2023.
10
Editorial: Autoimmune blistering diseases: advances in the understanding of pathogenesis and new therapeutic horizons.社论：自身免疫性水疱病：发病机制认识的进展与新的治疗前景
Front Med (Lausanne). 2023 Jul 12;10:1243878. doi: 10.3389/fmed.2023.1243878. eCollection 2023.